Key result
Control angiography or additional PCI after tirofiban shows no benefit over no procedure for major events.
Why the study?
The study aimed to investigate the effect of control imaging after intravenous tirofiban infusion on clinical outcomes in patients with ACS undergoing PCI.
Does control coronary angiography after index PCI and tirofiban infusion reduce cardiovascular events in patients with acute coronary syndrome?
Cohort (n=217)
No
Does control coronary angiography after index PCI and tirofiban infusion reduce cardiovascular events in patients with acute coronary syndrome?
Routine control angiography after PCI and tirofiban infusion in ACS patients does not appear to improve 1-year cardiovascular outcomes compared to no repeat angiography.
Answers are grounded in this paper and cite their sources.
No outcome benefit seen with routine control angiography; leaves open whether RCTs are needed to guide ACS management post-PCI.
OBJECTIVE: The aim of this study was to investigate the effect of control imaging after intravenous (IV) tirofiban infusion on the clinical outcome of patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). METHODS: Patients who underwent PCI between June 2020 and October 2023 at our tertiary referral hospital and received tirofiban infusion were analyzed. Primary composite endpoint was the combination of cardiovascular death, myocardial infarction, cerebrovascular accident, or unplanned revascularization during follow-up. RESULTS: A total of 217 patients (22.6% female, mean age: 58 ± 13 years) with ACS who received IV tirofiban therapy after PCI were compared in three groups: Patients without additional procedure (n = 131), patients undergoing control coronary angiography after index PCI (n = 43), and patients undergoing additional PCI after index PCI (n = 43). The most common reason for clinical intervention was STEMI (65.9%). After approximately 1 year of follow-up, primary composite endpoint of cardiac death, myocardial infarction, cerebrovascular accident, or unplanned revascularization was similar in all groups (30 [22.9%] vs. 15 [35%] vs. 12 [28%], p = 0.290). CONCLUSION: Repeat coronary angiography and additional PCI after tirofiban infusion in patients undergoing index PCI were associated with similar cardiovascular outcomes at 1-year follow-up compared with no repeat coronary angiography.
No takes yet. Share an insight, caveat, or question.
Güven et al. (2025) conducted a cohort in Acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) (n=217). Control coronary angiography or additional PCI vs. No additional procedure was evaluated on Combination of cardiovascular death, myocardial infarction, cerebrovascular accident, or unplanned revascularization (p=0.290). Control angiography or additional PCI after tirofiban infusion resulted in similar rates of cardiovascular death, MI, stroke, or revascularization vs no procedure.
Synapse has enriched 10 related papers. Consider them for comparative context: